Imaging of Injury Mechanism and Interaction of Intestinal Bacteria in Children With Mild Traumatic Brain Injury
1 other identifier
observational
300
1 country
1
Brief Summary
Traumatic brain injury (TBI) is the leading cause of disability in children and young adults. Children with moderate to severe TBI are typically at risk of poor functional outcome in terms of neurocognitive impairment and behavior problems. Neurocognitive impairments include deficits in attention and working memory, learning and memory, and executive functioning, whereas behavior problems include anxiety, depression and aggression. Neuroimaging techniques based on multi-modal magnetic resonance image (MRI) can detect the structural and functional brain abnormalities objectively and sensitively. Recent evidence indicates that even after mild TBI, children with risk factors for intracranial pathology are at risk of poor neurocognitive and behavioral outcome.Meanwhile, recently, the concept of "gut-brain axis" has been proposed and hint gut microbiota could shape the brain. Some studies have emphasized that human gut microbiota plays an important role in the pathogenesis and development of TBI. However, how the gut affects the brain in patients with TBI is unclear. Thus, combining analysis of neuroimaging and "gut-brain axis" will provide more information for finding the risk factors and imaging diagnostic markers of brain impairment in TBI. It will also helpful for explaining the underlying mechanisms of brain impairment in TBI, providing an objective basis for clinical diagnosis and prediction of the prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2021
CompletedFirst Posted
Study publicly available on registry
October 22, 2021
CompletedStudy Start
First participant enrolled
October 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 10, 2022
April 1, 2022
3.2 years
October 10, 2021
May 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline brain structure measures at 6 months and 12months
The changes of brain volume (mm3) are evaluated by structural MRI
baseline (early injury), post-traumatic for 6 months and 12 months
Change from baseline brain function measures at 6 months and 12months
The changes of brain functional connectivity intensity are evaluated by functional MRI
baseline (early injury), post-traumatic for 6 months and 12 months
Secondary Outcomes (3)
Changes from baseline cognitive condition at 6 months and 12months
baseline (early injury), post-traumatic for 6 months and 12 months
Changes from baseline behavior condition at 6 months and 12months
baseline (early injury), post-traumatic for 6 months and 12 months
Changes from baseline gut microbiota at 6 months and 12months
baseline (early injury), post-traumatic for 6 months and 12 months
Study Arms (2)
mTBI
A TBI is caused by a bump, blow, or jolt to the head that disrupts the normal function of the brain. Not all blows or jolts to the head result in a TBI.
HC
Healthy controls
Interventions
Eligibility Criteria
All of the patients of mTBI group are in-patients and out-patients in the nephrology department from three research centers. The subjects of control group are recruited from community.
You may qualify if:
- age 6-14 years at time of recruitment.
- GCS = 15-13.
- loss of consciousness duration≤30 min.
- post-traumatic amnesia duration ≤1 h.
You may not qualify if:
- previous TBI.
- visual or auditory disorder interfering with neurocognitive testing.
- current neurological condition affecting the central nervous system with known effects on neurocognitive functioning, other than TBI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Xian Jiaotong University
Xi'an, Shaanxi, 710061, China
Biospecimen
gut microbiota
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ming Zhang
First Affiliated Hospital of Xian Jiaotong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2021
First Posted
October 22, 2021
Study Start
October 25, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 10, 2022
Record last verified: 2022-04